Cory Watson Crowder & DeGaris, P.C.

On April 25, 2008, Actavis Totowa LLC issued a nationwide recall of all Digitek® (digoxin tablets). Digitek® is manufactured by Actavis Totowa, and distributed by Mylan Pharmaceuticals Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Digitek® is used to treat heart failure and abnormal heart rhythms. The tablets may be double the appropriate thickness and contain twice the approved level of the active ingredient.

The defective Digitek® tablets contain double the approved dosage of digoxin, the active ingredient. In patients with kidney/renal failure, this increases the risk of developing digitalis toxicity. Digitalis toxicity may cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, heart arrhythmia, bradycardia, and death.

We are representing individuals who died or were hospitalized for heart related injuries as a result of taking the improperly manufactured Digitek tablets. If you are interested in referring cases or associating with us on these cases, please contact one of our attorneys: Rick DiGiorgio rdigiorgio@cwcd.com or Ryan Lutz rlutz@cwcd.com or phone (800) 852-6299. We look forward to hearing from you.

Refer a Colleague
If you have a colleague who would benefit from receiving the eBulletin, contact Karen Lawrence at klawrence@cwcd.com.

Update Your Contact Information
You may change your email address, update your contact information or unsubscribe from the eBulletin at any time by contacting Karen Lawrence at klawrence@cwcd.com.